Common Stock, Shares Authorized of Enlivex Therapeutics Ltd. from 31 Dec 2013 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Enlivex Therapeutics Ltd. quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Dec 2013 to 30 Jun 2025.
  • Enlivex Therapeutics Ltd. Common Stock, Shares Authorized for the quarter ending 30 Jun 2025 was 45,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Enlivex Therapeutics Ltd. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 45,000,000 0 0% 30 Jun 2025 6-K 29 Aug 2025 2025 Q2
Q4 2024 45,000,000 0 0% 31 Dec 2024 6-K 29 Aug 2025 2025 Q2
Q2 2024 45,000,000 0 0% 30 Jun 2024 6-K 30 Aug 2024 2024 Q2
Q4 2023 45,000,000 0 0% 31 Dec 2023 20-F 30 Apr 2025 2024 FY
Q2 2023 45,000,000 0 0% 30 Jun 2023 6-K 01 Sep 2023 2023 Q2
Q4 2022 45,000,000 0 0% 31 Dec 2022 20-F 30 Apr 2024 2023 FY
Q2 2022 45,000,000 0 0% 30 Jun 2022 6-K 22 Aug 2022 2022 Q2
Q4 2021 45,000,000 0 0% 31 Dec 2021 20-F 10 Apr 2023 2022 FY
Q2 2021 45,000,000 0 0% 30 Jun 2021 6-K 06 Aug 2021 2021 Q2
Q4 2020 45,000,000 0 0% 31 Dec 2020 20-F 29 Apr 2022 2021 FY
Q2 2020 45,000,000 30 Jun 2020 6-K/A 13 Oct 2020 2020 Q2
Q4 2019 45,000,000 +33,138,927 +279% 31 Dec 2019 20-F 30 Apr 2021 2020 FY
Q4 2018 11,861,073 +10,611,073 +849% 31 Dec 2018 20-F 30 Apr 2020 2019 FY
Q4 2017 1,250,000 -8,750,000 -88% 31 Dec 2017 20-F/A 23 Jan 2020 2018 FY
Q4 2016 10,000,000 -40,000,000 -80% 31 Dec 2016 20-F 23 Apr 2018 2017 FY
Q4 2015 50,000,000 0 0% 31 Dec 2015 20-F 24 Feb 2017 2016 FY
Q4 2014 50,000,000 +33,386,861 +201% 31 Dec 2014 20-F 29 Mar 2016 2015 FY
Q4 2013 16,613,139 31 Dec 2013 20-F 31 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.